VITL connects cash-pay clinics to compounding pharmacies with real-time pricing and e-prescribing.
$7.5MSeries A
VITL's $7.5M Series A signals that the cash-pay clinic ecosystem is mature enough to support infrastructure plays—these clinics need operational plumbing as much as patient volume. If you're building in adjacent healthcare workflows (telehealth, direct-to-consumer pharma, specialty RX), this shows there's real willingness to pay for integration layers that reduce friction between fragmented providers.